Follow the progress of Hemolens Diagnostics
This website contains information intended only for persons professionally dealing with medical devices (e.g. for persons performing medical professions, for persons dealing with the distribution of medical devices). Please confirm that you are a medical device professional to proceed.
Follow the progress of Hemolens Diagnostics
June 27, 2022
We have developed a unique technology that enables the non-invasive diagnosis of coronary heart disease.
This method can significantly speed up diagnostics and reduce the patient risk associated with invasive procedures.
In the words of Wojciech Jeżewski, CEO of Hemolens Diagnostics:
“We believe in the evolution of medicine from invasive procedures to more patient-friendly, precise, and safe diagnostic methods”.
Our mission is to create and deliver unique technology for personalized, non-invasive, and precise diagnostics to reduce invasive procedures in healthcare.